Details of the Drug

General Information of Drug (ID: DM7BJFR)

• Drug Name: Cadralazine
• Synonyms: CGP-18684; CGP-22639; DC-826; ISF-2405; ISF-2469

Indication

Disease Entry	ICD 11	Status	REF
Hypertension	BA00-BA04	Approved	[1]

• ATC Code:
  C02DB04: Cadralazine
  C02DB: Hydrazinophthalazine derivatives
  C02D: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
  C02: ANTIHYPERTENSIVES
  C: CARDIOVASCULAR SYSTEM
• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C12H21N5O3
  Canonical SMILES: CCN(CC(C)O)C1=NN=C(C=C1)NNC(=O)OCC
  InChI: 1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19)
  InChIKey: QLTVVOATEHFXLT-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 2515
  ChEBI ID: CHEBI:31331
  CAS Number: 64241-34-5
  UNII: 8T96I3U713
  DrugBank ID: DB13452
  TTD ID: D09CIQ

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015